Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Michael Heider · SciRah

Researcher profile · Semantic Scholar

Michael Heider

Share profile

Michael Heider — researcher profile on SciRah

h-index: 9
Works: 18
Citations: 505

Most-cited papers

Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity
Ruth Eichner, Michael Heider, Vanesa Fernández-Sáiz, Frauke van Bebber +19 more
2016Nature Medicine181 citations
Semantic Scholar
Stress response silencing by an E3 ligase mutated in neurodegeneration
Diane L. Haakonsen, Michael Heider, Andrew J. Ingersoll, Kayla Vodehnal +4 more
2024Nature92 citations Open access
Semantic Scholar
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
Michael Heider, K. Nickel, Marion Högner, F. Bassermann
2021Oncology Research and Treatment67 citations Open access
Semantic Scholar
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
Michael Heider, Ruth Eichner, Jacob Stroh, V. Morath +18 more
2021Molecules and Cells55 citations Open access
Semantic Scholar
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
G. Heynen, F. Baumgartner, Michael Heider, U. Patra +21 more
2022Blood Advances28 citations Open access
Semantic Scholar
The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma
C. Paulmann, Ria Spallek, O. Karpiuk, Michael Heider +14 more
2022EMBO Journal22 citations Open access
Semantic Scholar
Molecular basis of SIFI activity in the integrated stress response
Zhi Yang, Diane L. Haakonsen, Michael Heider, Samuel R. Witus +4 more
2025Nature18 citations
Semantic Scholar
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
Jacob Stroh, A. Seckinger, Michael Heider, M. Rudelius +12 more
2021Blood Advances10 citations Open access
Semantic Scholar
Prognostic value of indoleamine 2,3 dioxygenase in patients with higher‐risk myelodysplastic syndromes treated with azacytidine
C. Müller-Thomas, Michael Heider, G. Piontek, M. Schlensog +5 more
2020British Journal of Haematology9 citations Open access
Semantic Scholar
Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma
V. Morath, Michael Heider, Markus Mittelhäuser, Hannes Rolbieski +5 more
2022EJNMMI Research7 citations Open access
Semantic Scholar
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.
Michael Heider, S. Grass, V. Dill, Stephanie Rämisch +5 more
2021Transfusion and Apheresis Science6 citations
Semantic Scholar
The molecular basis of integrated stress response silencing
Zhi Yang, Diane L. Haakonsen, Michael Heider, Samuel R. Witus +4 more
2024bioRxiv5 citations Open access
Semantic Scholar
Information-seeking failures of large language models in agentic clinical reasoning
K. Braitsch, L. Schmalbrock, Theresa Weltermann, A. Berdel +10 more
2026arXiv.org2 citations
Semantic Scholar
Localized heme sensing through a ternary molecular glue
Michael Heider, Clara Hipp, Zhi Yang, Han Xiao +8 more
2026bioRxiv2 citations Open access
Semantic Scholar
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response
K. Braitsch, S. Jeske, Jacob Stroh, Maike Hefter +13 more
2024Vaccines1 citations Open access
Semantic Scholar
MCT1 As Molecularly Validated Predictive Marker for Lenalidomide-Maintenance Therapy in Multiple Myeloma
Jacob Stroh, A. Seckinger, Michael Heider, Ruth Eichner +8 more
2019Blood1 citations Open access
Semantic Scholar
The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism
Michael Heider, Ruth Eichner, Jacob Stroh, Anna Kuisl +12 more
2019Blood0 citations Open access
Semantic Scholar
IMiDs mediate their anti-myeloma activity via destabilization of the CD147/MCT1 complex
Michael Heider
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Bassermann×11
Invite
F. Bassermann — researcher profile on SciRah
M. Rudelius×6
Invite
M. Rudelius — researcher profile on SciRah
K. Götze×6
Invite
K. Götze — researcher profile on SciRah
Jacob Stroh×6
Invite
Jacob Stroh — researcher profile on SciRah

×5

Invite

Ruth Eichner — researcher profile on SciRah

Invite

U. Keller — researcher profile on SciRah

Invite

B. Kuster — researcher profile on SciRah

Michael Rapé×4

Invite

Michael Rapé — researcher profile on SciRah

Vanesa Fernández-Sáiz×3

Invite

Vanesa Fernández-Sáiz — researcher profile on SciRah

Anne-Kathrin Garz×3

Invite

Anne-Kathrin Garz — researcher profile on SciRah

Invite

S. Lemeer — researcher profile on SciRah

Diane L. Haakonsen×3

Invite

Diane L. Haakonsen — researcher profile on SciRah